| Synthesis and evaluation of antifungal properties of a series of the novel 2-amino-5-oxo-4-phenyl-5,6,7,8-tetrahydroquinoline-3-carbonitrile and its analogues KVS Atul R. Gholapa, Kiran S. Totia, Fazal Shirazib, Ratna Kumaric, Manoj ... Bioorganic & Medicinal Chemistry 15 (21), 6705–6715, 2007 | 189 | 2007 |
| Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved MKB Avtar Singh Meena, Aanchal Sharma, Ratna Kumari, Naoshad Mohammad ... PLOS ONE 8 (4), e61524, 2013 | 92 | 2013 |
| Hepatocellular carcinoma treatment: hurdles, advances and prospects BM Kumari R, Sahu MK, Tripathy A, Unthansingh K Hepatic Oncology 5 (2), https://doi.org/10.2217/hep-2018-0002, 2018 | 90* | 2018 |
| Cdk5 phosphorylates non-genotoxically overexpressed p53 following inhibition of PP2A to induce cell cycle arrest/apoptosis and inhibits tumor progression AK Ajay, AK Upadhyay, S Singh, MV Vijayakumar, R Kumari, V Pandey, ... Molecular cancer 9, 1-15, 2010 | 55 | 2010 |
| Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models R Kumari, A Sharma, AK Ajay, MK Bhat Molecular Cancer 8, 1-19, 2009 | 40 | 2009 |
| Cyclin‐dependent kinase 9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines JHN Yik, Z Hu, R Kumari, BA Christiansen, DR Haudenschild Arthritis & Rheumatology 66 (6), 1537-1546, 2014 | 39 | 2014 |
| Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway AKAMKB RATNA KUMARI , SURBHI CHOUHAN ,SNAHLATA SINGH , RISHI RAJ CHHIPA Journal of Biosciences 42 (1), 31-41, 2017 | 26 | 2017 |
| The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance R Kumari, H Li, DR Haudenschild, F Fierro, CS Carlson, P Overn, L Gupta, ... Carcinogenesis 33 (11), 2076-2083, 2012 | 23 | 2012 |
| The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways RK Anindita Tripathy, Sudhir Thakurela, Manoj Kumar Sahu, Kanishka ... PLoS ONE 13 (12), e0208194, 2018 | 21 | 2018 |
| Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation RR Chhipa, R Kumari, AK Upadhyay, MK Bhat Experimental cell research 313 (19), 3945-3958, 2007 | 19 | 2007 |
| Fatty changes associated with N-Nitrosodiethylamine (DEN) induced hepatocellular carcinoma: a role of sonic hedgehog signaling pathway KR Tripathy A, Thakurela S, Sahu MK, Uthansingh K, Singh A, Narayan J, Ajay ... Genes Cancer. 11 (1-2), 66-82, 2020 | 9 | 2020 |
| The Oncogene LRF Stimulates Proliferation of Mesenchymal Stem Cells and Inhibits Their Chondrogenic Differentiation PEDC Jasper H.N. Yik, Huan Li, Chitrangada Acharya, Ratna Kumari, Fernando ... Cartilage 4 (4), 329-338, 2013 | 4 | 2013 |
| The therapeutic relevance of co-targeting Wnt-Hh signalling pathways in hepatocellular carcinoma KR Tripathy A, Sahu MK, Uthansingh K, Singh A, Narayan J Acta Scientific Gastrointestinal Disorders (ASGIS) 3 (3), 01-09., 2020 | | 2020 |
| Bridging the Gap between Pre-Clinical and Clinical Studies in Cancer Research R Kumari Novel approaches in cancer study 2 (4), 10.31031/NACS.2019.02.000545, 2019 | | 2019 |
Manoj Kumar BhatNational Centre for cell Science在 nccs.res.in 的电子邮件经过验证
